Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine Partners on Study of Young Adults with Lung Cancer

NEW YORK (GenomeWeb) – Foundation Medicine is partnering with the Addario Lung Cancer Medical Institute and the Bonnie J. Addario Lung Cancer Foundation for a study aimed at improving treatment options for young adults with lung cancer.

The multicenter, international prospective study, called the Genomics of Young Lung Cancer, will use Foundation's FoundationOne test for solid tumors, along with expertise from leading academic institutions and peer-reviewed literature, to determine better treatment options and tailor therapies for young adults with lung cancer. FoundationOne uses next-generation sequencing to provide a genomic profile of solid tumors to identify the molecular changes in a patient's tumor, and then matches those changes with relevant targeted therapies and clinical trials.

Citing statistics from the American Cancer Society, Foundation said that of the 224,000 new cases of lung cancer expected to be diagnosed this year, about 3,700 will be patients under the age of 45. Such patients often do not have the characteristic symptoms and signs typical of a patient with the disease, ALCMI President and COO Steven Young said.

"Despite an environment of rapidly expanding treatment options available for lung cancer, a lack of understanding of comprehensive testing for the molecular drivers of the disease specifically in young adults restricts the effective treatments available to patients at a tragically early stage in their lives," he said in a statement. "Through this initial study, we hope to address this gap in knowledge and access, and lay the groundwork to routinely identify more effective treatment options for these patients."

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.